immunological diagnostic method
Sponsors
University of California, San Francisco, Wake Forest University Health Sciences, Mayo Clinic, Milton S. Hershey Medical Center, City of Hope Medical Center
Conditions
CancerChronic Myeloproliferative DisordersGraft Versus Host DiseaseInfectionLeukemiaLymphomaMetastatic CancerMultiple Myeloma and Plasma Cell Neoplasm
Phase 1
GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer
CompletedNCT00305669
Start: 2006-07-31End: 2014-06-30Updated: 2014-06-25
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
NCT00769613
Start: 2008-08-31Target: 20Updated: 2013-12-18
Phase 2
Unknown Phase
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy
CompletedNCT00373035
Start: 2006-02-28Target: 60Updated: 2017-01-19
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
TerminatedNCT00813501
Start: 2008-06-30End: 2010-06-30Updated: 2011-03-07
Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia
CompletedNCT00900380
Start: 2006-03-28End: 2013-12-30Updated: 2017-05-19
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
CompletedNCT00899496
Start: 2005-09-30End: 2009-10-23Updated: 2017-05-30
Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia
CompletedNCT01290107
Start: 2011-02-28End: 2016-05-31Target: 9Updated: 2016-05-18